
Researchers at the University of Central Florida (UCF) repurposed protein kinase inhibitors, originally developed for cancer treatment, for accelerated drug therapy for malaria. Their study identified a specific inhibitor, BI-2536, demonstrating strong anti-malarial properties. This approach of repurposing existing drugs offers a faster path to drug discovery, addressing the urgent need for more effective malaria treatments.
Like
Save
Share